A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects - Concepedia

Concepedia

Publication | Open Access

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

DOI Full Paper Access

80

Citations

31

References

2016

Year

Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton, Thomas Marbury, Eva Wagner, Eva Kreitmeir, Siegfried Röesch, Alfred von Krempelhuber, Philip Young, Richard Nichols,

Abstract

ClinicalTrials.gov NCT00857493.

References

	Year	Citations

Page 1